Sylvia E. Rosas, M.D., MSCE
Assistant Professor of Medicine
Department: Medicine
Contact information
Room 113
1 Founders Pavilion/HUP
3400 Spruce Street
Philadelphia, PA 19104
1 Founders Pavilion/HUP
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-615-3446
Fax: 215-615-3447
Fax: 215-615-3447
Email:
sylvia.rosas@uphs.upenn.edu
sylvia.rosas@uphs.upenn.edu
Publications
Education:
M.D.
Colegio Mayor de Nuestra Senora del Rosario, Bogota, Colombia, 1990.
(Business Administration)
Wharton Management Program, University of Pennsylvania, 2002.
M.S.C.E. (Clinical Epidemiology and Biostatistics Program)
University of Pennsylvania, 2003.
Permanent linkM.D.
Colegio Mayor de Nuestra Senora del Rosario, Bogota, Colombia, 1990.
(Business Administration)
Wharton Management Program, University of Pennsylvania, 2002.
M.S.C.E. (Clinical Epidemiology and Biostatistics Program)
University of Pennsylvania, 2003.
Description of CVI Expertise
CVI Program Unit(s):Lipid / Atherosclerosis / CAD / ACS / Prevention
CVI Research Description:
Dr. Rosas's research focuses on examining the role of novel risk factors [for example, inflammatory markers, homocysteine, Lipoprotein(a)] in the development and progression of cardiovascular disease in patients with chronic kidney disease. Dr. Rosas is the principal investigator on several on going studies evaluating the use of non-invasive cardiovascular procedures such as electron beam computed tomography and carotid intima-media thickness in CKD patients (including dialysis and transplant recipients).
Selected Publications
Rassi AN, Cavender MA, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Rosas SE, Zhao X, Schwamm LH, Bhatt DL. : Temporal Trends and Predictors in the Use of Aldosterone Antagonists Post-Acute Myocardial Infarction. Journal of the American College of Cardiology 61(1): 35-40, Jan 2013.Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY; on behalf of the Chronic Renal Insufficiency Cohort (CRIC) study investigators.: Urine neutrophil gelatinase-associated lipocalin (NGAL) level and risk of progressive chronic kidney disease: results from the CRIC study. Kidney International 2013.
Jane F Ferguson, Gregory J Matthews, Raymond R Townsend, Dominic S Raj, Peter A.Kanetsky, Matthew Budoff, Michael J Fischer, Sylvia E Rosas, Radhika Kanthety, Mahboob Rahman, Stephen R Master, Atif Qasim, Mingyao Li, Nehal N. Mehta, Haiqing Shen, Braxton D Mitchell, Jeffrey R O’Connell, Alan R Shuldiner, Weang Kee Ho1, Robin Young, Asif Rasheed, John Danesh, Jiang He, John W Kusek, Akinlolu O Ojo, John Flack, Alan S Go, Crystal A Gadegbeku, Jackson T Wright, Danish Saleheen,Harold I Feldman, Daniel J Rader, Andrea S Foulkes, Muredach P Reilly and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators: Candidate Gene Association Study of Coronary Artery Calcification in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study. Journal of the American College of Cardiology 2013.
B Mohamed, W Yang, H Litt and SE Rosas: Valvular Calcification, Inflammation and Mortality in Dialysis Patients Journal of Heart Valve Disease 2013.
Rosas SE, Feldman HI: Synthetic Vascular Hemodialysis Access vs Native Arteriovenous Fistula: A Cost-Utility Analysis. Annals of Surgery 255(1): 181-6, Jan 2012
Khan AM, Yang W, Chirinos J, Litt H,Rosas SE: FGF-23 and the progression of coronary arterial calcification in patients new to dialysis Clinical Journal of the American Society of Nephrology 7(12): 2017-22, December 2012.
Adeseun GA, Xie D, Wang X, Joffe MM, Mohler III ER, Townsend RR, Budoff M, Rosas SE. : Carotid Plaque, Carotid Intima-Media Thickness, and Coronary Calcification Equally Discriminate Prevalent Cardiovascular Disease in Kidney Disease American Journal of Nephrology 36(4): 342-347, December 2012.
Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD. Journal of the American Society of Nephrology 23(10): 1725-34, October 2012.
Vasaiwala S, Cannon CP, Fonarow GC, Peacock WF, Laskey W, Schwamm LH, Liang L, Hernandez AF, Peterson ED, Rosas SE, Bhatt DL; Get With The Guidelines Steering Committee and Investigators: Quality of Care and Outcomes Among Patients With Acute Myocardial Infarction by Level of Kidney Function at Admission: Report From the Get With The Guidelines Coronary Artery Disease Program Clinical Cardiology 35: 541-7, September 2012.
Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, Chen J, Feldman H, Gutierrez OM, Lash J, Leonard MB, Negrea L, Rosas SE, Anderson AH, Townsend RR, Wolf M, Isakova T. : Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care 35(5): 994-1001, May 2012.